Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.91

+1.5%

Nov 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2121)	1/14/2008 1:52:11 PM
From: Jibacoa	Read Replies (1) of 3722

ZGEN traded earlier today above last Tuesday's H of $12.69 & is still up 4.09% with volume above its ADV. bigcharts.marketwatch.com Its CEO, Bruce L.A. Carter, Ph.D.,is scheduled to present at the Stanford Group Company Annual Healthcare Conference in Washington, D.C. on Thursday. On Tuesday, was when it announced that it has initiated a PII of IL-21 in combination with Nexavar (sorafenib) tablets in patients with advanced renal cell cancer. In the PI of IL-21 in combination with Nexavar in patients with renal cell cancer,which were presented in Oct at the AACR Conference,the data indicated that the combination was well tolerated,& evidence of anti-tumor activity was documented in the majority of the patients. ZGEN insiders reportedly hold > 45% & it also has a good institutional following.<g> finance.yahoo.com The short position came down some in the last month, but is still > 15x its ADV. ZGEN needs to close above its Dec H of $15.16 in order to get off from the DT coming from its Jan2006 H at $16.63 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next